𝔖 Bobbio Scriptorium

✦ LIBER ✦

134 O - The S.M.A.C. study: large scale collaborative trial of adjuvant therapy in colon cancer

✍ Scribed by A. Alexanian; L. Boffi; B. Arcangeli; S. Banducci; B. Tardio; S. Palazzo; G.P. Consani

Book ID: 116168409
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 140 KB
Volume: 32
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(96)84888-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A prospective randomised trial to study

A prospective randomised trial to study the role of levamisole and interferon alfa in an adjuvant therapy with 5-FU for stage III colon cancer

✍ Schippinger, W; Jagoditsch, M; Sorré, C; Gnant, M; Steger, G; Hausmaninger, H; M 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 119 KB

634 POSTER Post-study treatment does not

634 POSTER Post-study treatment does not influence outcome in the X-ACT phase III trial of capecitabine (X) vs. bolus 5-FU/LV as adjuvant therapy for patients (pts) with Dukes' C colon cancer

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Clinical update: Impact of Adjuvant Ther

Clinical update: Impact of Adjuvant Therapy on Quality of Life in Women with Node Positive Operable Breast Cancer. Hurny, C., Bernhard, J., Coates, A.S., Castiglione-Gertsch, M., Peterson, H.F. et al. for the International Breast Cancer Study Group (1996) 347, No. 9011, 1279–1284.

✍ William Breitbart; Ann Cull; Donna Greenberg 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 2 views

Optimized Duration of Clopidogrel Therap

Optimized Duration of Clopidogrel Therapy Following Treatment with the Endeavor Zotarolimus-Eluting Stent in Real-World Clinical Practice (OPTIMIZE) Trial: Rationale and design of a large-scale, randomized, multicenter study

✍ Fausto Feres; Ricardo A. Costa; Deepak L. Bhatt; Martin B. Leon; Roberto V. Bote 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 316 KB

Randomized Phase III trial comparing ret

Randomized Phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical Stage I nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German testicular cancer study group: Albers P, Siener R, Krege S, Schmelz HU, Dieckmann KP, Heidenreich A, Kwasny P, Pechoel M, Lehmann J, Kliesch S, Köhrmann KU, Fimmers R, Weissbach L, Loy V, Wittekind C, Hartmann M, German Testicular Cancer Study Group, Department of Urology, Klinikum Kassel GmbH, Kassel, Germany

✍ Donald L. Trump 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Multiple newly identified loci associate

Multiple newly identified loci associated with prostate cancer susceptibility: Eeles RA, Kote-Jarai Z, Giles GG, Olama AA, Guy M, Jugurnauth SK, Mulholland S, Leongamornlert DA, Edwards SM, Morrison J, Field HI, Southey MC, Severi G, Donovan JL, Hamdy FC, Dearnaley DP, Muir KR, Smith C, Bagnato M, Ardern-Jones AT, Hall AL, O'Brien LT, Gehr-Swain BN, Wilkinson RA, Cox A, Lewis S, Brown PM, Jhavar SG, Tymrakiewicz M, Lophatananon A, Bryant SL, UK Genetic Prostate Cancer Study Collaborators, British Association of Urological Surgeons' Section of Oncology, UK ProtecT Study Collaborators Horwich A, Huddart RA, Khoo VS, Parker CC, Woodhouse CJ, Thompson A, Christmas T, Ogden C, Fisher C, Jamieson C, Cooper CS, English DR, Hopper JL, Neal DE, Easton DF, The Institute of Cancer Research, Surrey, UK

✍ James Brooks 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 37 KB